A look at why some families dealing with serious illnesses are having to put treatment on hold over prescription drug shortages – with comments from our Yoram Unguru

Quick Read

Tens of millions of dollars have been spent in a legal fight between two US scientific powerhouses, but a recent ruling by the US Patent Office could signal its end

Quick Read

As pharmaceutical companies seek to profit from the curative wonders of human feces, doctors worry about new regulations, higher prices and patients attempting DIY cures

Quick Read

Lawmakers could help some stay open. The decline of rural hospitals has been a slow-moving train wreck. It’s now accelerating

Quick Read

New York City Council Speaker Corey Johnson, who is HIV-positive, has endorsed a plan to make Truvada, or PrEP, generic

Quick Read

Data from clinical trials have long been locked away, some in this principal investigator’s computer bank, some in that pharmaceutical company’s cloud. For years we have been talking about opening up those vaults and freeing these data. The key has finally turned

Quick Read

Women, especially pregnant women, are frequently excluded from immunisation programmes. The reasoning is often flawed—and the consequences can be fatal – with comments from our Carleigh Krubiner

Quick Read

Big pharma is partnering with influencers to sell new drugs and medical devices

Quick Read